Trends in Serum Lipid Levels of a 10- and 13-Year-Old Population in Fukuroi City, Japan (2007-2017).
child
cholesterol
epidemiology
lipoproteins
Journal
Journal of epidemiology
ISSN: 1349-9092
Titre abrégé: J Epidemiol
Pays: Japan
ID NLM: 9607688
Informations de publication
Date de publication:
05 Jan 2020
05 Jan 2020
Historique:
pubmed:
18
12
2018
medline:
1
7
2020
entrez:
18
12
2018
Statut:
ppublish
Résumé
Current trends in serum lipid levels among children are likely to be important predictors of future cardiovascular disease prevalence. However, no studies have examined trends in low-density lipoprotein cholesterol (LDL-C) levels in Japanese children. We investigated trends in LDL-C levels from 2008 through 2017 and HDL-C levels from 2007 through 2017 in a population of 10- and 13-year-old children in Fukuroi City, Japan. We analyzed 17,838 children, accounting for 93.8% of all fifth and eighth graders in the entire city. Adverse lipid levels were defined as follows: 130 mg/dL or higher for LDL-C, and lower than 40 mg/dL for HDL-C. The Jonckheere-Terpstra and Cochran-Armitage tests were used to evaluate secular trends in mean serum lipid levels and prevalence of dyslipidemia, respectively. There were no significant trends in BMI during the study period. In children aged 10 years, serum levels of LDL-C and HDL-C showed significant positive associations with calendar year during the study period for both sexes. A significant increase in HDL-C levels was observed in girls aged 13 years. On the other hand, no significant trends were observed in the prevalence of high LDL-C or low HDL-C regardless of sex or age, while the prevalence of high non-HDL-C showed a significant increase in boys. In the Fukuroi population, serum levels of LDL-C and HDL-C slightly increased in both boys and girls aged 10 years, and HDL-C levels slightly increased in girls aged 13 years, during the past decade.
Sections du résumé
BACKGROUND
BACKGROUND
Current trends in serum lipid levels among children are likely to be important predictors of future cardiovascular disease prevalence. However, no studies have examined trends in low-density lipoprotein cholesterol (LDL-C) levels in Japanese children.
METHODS
METHODS
We investigated trends in LDL-C levels from 2008 through 2017 and HDL-C levels from 2007 through 2017 in a population of 10- and 13-year-old children in Fukuroi City, Japan. We analyzed 17,838 children, accounting for 93.8% of all fifth and eighth graders in the entire city. Adverse lipid levels were defined as follows: 130 mg/dL or higher for LDL-C, and lower than 40 mg/dL for HDL-C. The Jonckheere-Terpstra and Cochran-Armitage tests were used to evaluate secular trends in mean serum lipid levels and prevalence of dyslipidemia, respectively.
RESULTS
RESULTS
There were no significant trends in BMI during the study period. In children aged 10 years, serum levels of LDL-C and HDL-C showed significant positive associations with calendar year during the study period for both sexes. A significant increase in HDL-C levels was observed in girls aged 13 years. On the other hand, no significant trends were observed in the prevalence of high LDL-C or low HDL-C regardless of sex or age, while the prevalence of high non-HDL-C showed a significant increase in boys.
CONCLUSIONS
CONCLUSIONS
In the Fukuroi population, serum levels of LDL-C and HDL-C slightly increased in both boys and girls aged 10 years, and HDL-C levels slightly increased in girls aged 13 years, during the past decade.
Identifiants
pubmed: 30555117
doi: 10.2188/jea.JE20180164
pmc: PMC6908840
doi:
Substances chimiques
Cholesterol, HDL
0
Cholesterol, LDL
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
24-29Références
Am J Clin Nutr. 2000 Nov;72(5 Suppl):1379S-1383S
pubmed: 11063481
Med Princ Pract. 2014;23(2):99-111
pubmed: 24334831
Prev Med. 2011 May;52(5):381-6
pubmed: 21371493
Prev Med. 1985 Mar;14(2):203-16
pubmed: 4048083
J Epidemiol. 2000 Jul;10(4):255-61
pubmed: 10959608
Atherosclerosis. 2001 Apr;155(2):487-97
pubmed: 11254921
Am J Epidemiol. 1994 Dec 15;140(12):1096-110
pubmed: 7998592
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
JAMA. 2003 Nov 5;290(17):2277-83
pubmed: 14600186
Am J Epidemiol. 1991 May 1;133(9):884-99
pubmed: 2028978
Int J Sports Med. 2002 May;23 Suppl 1:S39-43
pubmed: 12012261
Toxicol Sci. 2010 Jan;113(1):4-26
pubmed: 19770482
J Epidemiol. 2016 Dec 5;26(12):637-645
pubmed: 27397598
J Epidemiol. 2004 May;14(3):78-82
pubmed: 15242063
Ann Hum Biol. 2006 Jul-Aug;33(4):444-53
pubmed: 17060068
Lancet. 2004 Jan 31;363(9406):369-70
pubmed: 15070569
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
JAMA. 1999 Feb 24;281(8):727-35
pubmed: 10052443
JAMA. 2012 Aug 8;308(6):591-600
pubmed: 22871871
Am J Clin Nutr. 1977 Apr;30(4):582-91
pubmed: 851088
JAMA. 2003 Nov 5;290(17):2271-6
pubmed: 14600185
Atherosclerosis. 1988 Aug;72(2-3):143-56
pubmed: 3214466
Environ Health Perspect. 2003 Apr;111(4):642-6
pubmed: 12676629
Int J Epidemiol. 2003 Dec;32(6):1105-10
pubmed: 14681284
Prev Med. 1991 Nov;20(6):713-24
pubmed: 1766943
J Epidemiol. 2010;20(3):212-8
pubmed: 20208399
Environ Health Perspect. 2000 Jun;108 Suppl 3:451-5
pubmed: 10852844